Evidence map›Paper›PMID 24371760›Full record

ArticleLeukemia research reports2012

New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: Shared genetic factors or simple coincidence?

Mutende J Sikuyayenga, Craig B Reeder, Joseph R Mikhael

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mutende J SikuyayengaDivision of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.
Craig B ReederDivision of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.
Joseph R MikhaelDivision of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.
Mayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Myeloma and Mantle Cell Lymphoma are well defined hematological malignancies. Understanding of their pathogeneses has led to new therapies and increased survival. We report on a 64-yr-old female who was diagnosed with mantle cell lymphoma in 2003, then multiple myeloma in 2010. We identified only few other cases of concomitant MM and MCL. We also explored the importance of t(11;14)(q13;q32). The development of these two disorders in the same patient may simply be due to chance; however, it may also represent a common genetic hit affecting the B-cell population leading to development of two different malignancies.

Indexed as

FDG, fluorodeoxyglucoseG-CSF, granulocyte colony-stimulating factorIgH, immunoglobin heavy (chain)Mantle cell lymphomaMCL, mantle cell lymphomaMM, multiple myelomaMultiple myelomaPBSCT, peripheral blood stem cell transplantationt(11;14)(q13;q32)VCD, velcade (bortezomib) cyclophosphamide dexamethasoneVDJ, variable, diverse, joining (region)VRD, velcade revlimid (lenalidomide) dexamethasone

Identifiers

PMID24371760
PMCPMC3787821
OpenAlexW2152566214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.